Opinion|Videos|July 29, 2024

Biosimilars in the Commercial Sector

Dr. Cannon discusses payers and PBMs making decisions about biosimilars in the commercial sector.

Video content above is prompted by the following:

  • How are payers and PBMs making decisions about biosimilars in the commercial sector?

a. What key factors are considered for formulary decisions in the commercial sector?

b. Discussion points: What makes the commercial sector unique, employer/payer payment models.